News
News from us and our partners
Tags
Topics
0 results
- News
Promising Phase I interim data for ExPEC vaccine program triggers first milestone payment in clinical co-development with Janssen
- News
Ascendis Pharma A/S Announces Initiation of a Phase 1 Single Ascending Dose Study of TransCon Treprostinil
- News
Ascendis Pharma A/S Announces Initiation of a Phase 1 Single Ascending Dose Study of TransCon Treprostinil
- News
Mission appoints Anker Lundemose as Chief Executive Officer
- News
Shockwave Medical Announces CE Mark Approval of its Lithoplasty System for the Treatment of Peripheral Artery Disease